GB:FAB Stock Latest News
Company AnnouncementsFusion Antibodies wins complex antibody project from major pharma client1w ago
Company AnnouncementsFusion Antibodies Wins Complex Antibody Development Contract with Global Pharma Client1w ago- Company AnnouncementsFusion Antibodies AGM Resolutions Passed as Company Targets Expanding Antibody Market2w ago
Company AnnouncementsFusion Antibodies Warns on H1 Trading but Flags Progress in DR5 Programme and OptiMAL Platform2w ago
Company AnnouncementsFusion Antibodies launches revamped customer-focused website to showcase antibody services4w ago
Company AnnouncementsFusion Antibodies Publishes 2026 Annual Report and Sets AGM Date1M agoCompany AnnouncementsFusion Antibodies boosts margins and cash as OptiMAL launch and patents strengthen growth platform1M ago
Company AnnouncementsFusion Antibodies boosts margins and cash as OptiMAL launch and patents advance1M ago
Company AnnouncementsFusion Antibodies Wins Canadian Patent for OptiMAL Antibody Library1M ago
Company AnnouncementsFusion Antibodies to unveil annual results with open investor presentation1M ago- Company AnnouncementsFusion Antibodies Secures Australian Acceptance for Antibody Library Patent2M ago
Company AnnouncementsFusion Antibodies boosts management incentives with new share option grant3M ago
Company AnnouncementsInvestor Simon Peace lifts stake in Fusion Antibodies to just over 4%4M ago
Company AnnouncementsFusion Antibodies secures Canadian patent allowance for antibody library platform4M ago
Company AnnouncementsFusion Antibodies Advances Grant-Funded DR5 Cancer Antibody Programme4M ago
Company AnnouncementsFusion Antibodies Updates Share Capital After Employee Option Exercise5M ago
Company AnnouncementsInvestor Simon Peace Builds 3.3% Stake in Fusion Antibodies5M ago
Company AnnouncementsFusion Antibodies secures key Japanese patent to bolster antibody library platform5M ago
Company AnnouncementsFusion Antibodies lifts margins, secures pharma deals and U.S. patent as pipeline broadens6M agoCompany AnnouncementsFusion Antibodies Sells Antibody IP to Finn Therapeutics in £250,000 Deal7M ago
